Qube Research & Technologies (QRT)
APTO

Qube Research & Technologies (QRT)’s Aptose Biosciences, Inc. APTO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27
Closed -$53K – 2545
2020
Q4 		$53K Buy
+27
New +$63.4K ﹤0.01% 1694
2020
Q3 		– Sell
-110
Closed -$311K – 2214
2020
Q2 		$311K Buy
+110
New +$355K ﹤0.01% 1283

Other funds holding APTO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s APTO Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Aptose Biosciences, Inc. (APTO) in Q1 2021, closing a stake of 27 shares — an estimated $53K sold.

Qube Research & Technologies (QRT) first reported a position in APTO in Q2 2020 and held it in 2 quarters. The position peaked at $311K in Q2 2020. 70 funds tracked by Wall St. Rank hold APTO as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Aptose Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 27 Aptose Biosciences, Inc. shares in Q1 2021, an estimated $53K.
  • Qube Research & Technologies (QRT) first reported a position in Aptose Biosciences, Inc. in Q2 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Aptose Biosciences, Inc. position peaked at $311K in Q2 2020.
  • 70 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.